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Introduction
The nasal polyp seems to represent the end-stage of
longstanding inflammation in patients with chronic
rhinosinusitis [1]. The histomorphologic analysis of
nasal polyps in patients suffering from chronic rhi-
nosinusitis reveals frequent epithelial damage, thick-
ened basement membrane, and mostly edematous to
fibrotic stroma [2]. The accumulation of a variety of
inflammatory cells (plasma cells, eosinophils, neu-
trophils, mast cells, macrophages, dendritic cells,
monocytes, and lymphocytes and their subgroups)
was also found in the nasal polyps [3,4]. Eosinophils
made up the predominant cellular infiltration in
about 80% of the nasal polyps occurring in members
of the Caucasian population. Additionally, increased
numbers of eosinophils were observed in patients
suffering from asthma and aspirin sensitivity, while
neutrophils and lymphocytes were the two predomi-
nant types of cells infiltrating nasal polyps in
patients with cystic fibrosis as well as the nasal
mucosa of those suffering from chronic rhinosinusi-
tis without nasal polyps [4].
Detailed histological examination enabled the
selection of three different types of nasal polyps: those
infiltrated predominantly by eosinophils with thick-
ened basal membrane, those infiltrated by a mixed
inflammatory cell pattern with a predominance of
mononuclear cells without thickening of the basal
membrane, and those infiltrated predominantly by
neutrophils [5]. 
Sakaguchi and colleagues have identified a popula-
tion of lymphocytes as CD4+ highly expressing CD25
(Treg) and able to prevent autoimmunity in a murine
model; these are called T regulatory cells [6]. A tran-
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scription factor forkhead box P3 (Foxp3) has been
determined to be more specific for the identification
of Treg cells than other types of antigens [7,8,9]. The
CD4+CD25high Foxp3+ Treg cells are able to active-
ly inhibit T lymphocytes, dendritic cells, natural
killer cells (NK), and B cells in a cell to cell contact
and dose-dependent manner [10]. Furthermore, Treg
cells have been examined in patients with allergy
and atopy.  The cells were present in the majority of
such patients and their regulatory functions were
normal [11]. A break in Treg cell-mediated suppres-
sion has been observed at high doses of allergen con-
centration [12] or activation with superantigens [13].
The down-regulation of CD4+CD25+Foxp3+ T cells
has been demonstrated in patients with nasal polyps
when compared to healthy controls. Additionally, an
elevation of the CD4+CD25+Foxp3+ T cells has
been observed following steroid therapy [14].
Macrophages and dendritic cells have also been
identified in nasal polyps [15,16]. The accumulation
of mannose-receptor positive macrophages reported
in nasal polyps in cell aggregates suggests that they
play a key role in the pathogen-macrophage interac-
tion within nasal polyps [15]. The number of
macrophages has been noted to be significantly high-
er in eosinophilic than in lymphocytic nasal polyps
[5]. The disturbance of the immune cell activity reg-
ulation that has been observed in nasal polyps is also
typical of the tumor microenvironment. Reportedly,
tumor-associated macrophages play an important role
in immune suppression. Certainly, it has been demon-
strated that tumor-associated macrophages are able to
promote tumor growth and metastasis acting on
tumor cells [17]. B7-H4, as expressed by certain
macrophages, consists of co-stimulatory molecules,
members of the membrane protein B7 family that is
responsible for the negative regulation of T-cell-
mediated immune response [18,19,20]. Kryczek and
coworkers have recently demonstrated the presence
of a population of B7-H4 positive macrophages in
cases of human ovarian carcinoma. These cells are
characterized by a suppressive function in a manner
similar to CD4+ Treg cells. Furthermore, these two
populations of suppressive cells interact with each
other--CD4+ Treg cells stimulate APC (antigen pre-
senting cell) B7-H4 expression and enable APC sup-
pressive activity through B7-H4 induction. It has also
been shown that tumor environmental IL-6 and IL-10
stimulate monocyte/ macrophage B7-H4 expression.
Treg cells can trigger APC IL-10 production which in
turn stimulates B7-H4 expression and renders APCs
suppressive through B7-H4 [21,22]. Recently, we
have identified the presence of B7-H4-expressing
macrophages in decidua during pregnancy when the
mechanisms regulating the local immune tolerance
develop [23,24]. 
As macrophages probably participate in immune
tolerance in nasal polyps [5], it is likely that there is a
relationship between the development and persistence
of nasal polyps and the emergence of the local sup-
pressive environment found in these polyps. 
To reiterate, the aim of our present study has been to
evaluate the presence of two regulatory subpopulations
of cells, namely Treg cells and B7-H4-positive
macrophages, in the microenvironment of nasal polyps. 
Methods
Clinical material. All the tissue samples were derived from the
Otolaryngology Department of the Jagiellonian University during
routine endonasal sinus surgery. Thirty patients were recruited for
the study from those who had undergone functional endoscopic
sinus surgery between January 2005 and November 2008; from
this group patients who had undergone steroid treatment (inhaled
and/ or oral steroids) during the 3 months prior to the surgery were
automatically excluded from the study. Only those patients who
had not been treated with steroids of any kind were considered
since according to the literature, steroids can influence the number
of Treg cells in nasal polyps. All tissue samples were histopatho-
logically verified. Pathological analysis using the classical hema-
toxylin and eosin staining techniques after fixation in a formalin of
the surgically removed material was performed in the Pathology
Department of the Jagiellonian University by an experienced
pathologist. The predominant immune cell infiltration in the nasal
polyps was then determined by histopathological examination.
Based on this examination, two distinct types of polyps were
selected---eosinophilic and lymphocytic. The criteria for the selec-
tion of the different types of nasal polyps were as follows:
• Lymphocytic nasal polyps have a predominant infiltration of
mononuclear cells; the percentage of eosinophils in these
polyps should not exceed 10%, and the basal membrane should
not be thickened. Eosinophilic nasal polyps, on the other hand,
have an inflammatory infiltrate composed mainly of
eosinophils (more than 50% of the total number of inflamma-
tory cells), and the basal membrane is thickened. 
• The tissue samples were thus divided into two main groups
according to the predominant type of immune cell infiltration:
eosinophilic nasal polyps (ENP) predominantly infiltrated by
eosinophils (8 cases), and lymphocytic nasal polyps (LNP)
predominantly infiltrated by lymphocytes (6 cases).
The clinical characteristics of the subjects are presented in
Table 1. 
Isolation of mononuclear cells from nasal polyps. The nasal
polyps were cut into small fragments and disintegrated by smashing
these through a 40 μm cell-strainer. The analyzed cells were studied
after freezing -following process. Briefly,  the tissue was dissociated
and the cell pellet was treated with 1X ammonium chloride (8.99 g
NH4Cl, 1.0 g KHCO3, 37 mg tetrasodium EDTA dissolved in 1l
H2O, pH 7.3) in order to get rid of any erythrocytes. The cells were
then frozen in a freezing medium (10% DMSO, 20 % FBS, 70%
DMEM). Prior to staining the cells were fow, spun down, washed in
cold 1×DPBS, and counted. 1×106 cells were used for staining.    
Flow cytometry. The cell phenotype was analyzed with the panel
of mAb – CD4 FITC, CD25 APC, and FOXP3 PE (Pharmingen).
Briefly stated 1×106 cells were suspended in 60 μl of 1×DPBS. 20
μl of CD4FITC and CD25 APC was added to the tube and it was
incubated in the dark for 30 min at 4°C. After incubation the cells
were washed twice in cold 1×DPBS. After a second wash the cell
pellet was resuspended in 1× buffer A and incubated at room tem-
perature for 10 min. The cells were then spun down and the liquid
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decanted. Next, the cells were washed twice in PERM WASH
buffer. For permabilization they were suspended in 0.5 ml of buffer
C and incubated for 30 min. Following permabilization the cells
were washed twice again in PERM WASH. In order to perform the
staining the cells were suspended in 80 μl of PERM WASH buffer
and 20 μl of PoxP3 PE antibody was added and the staining was
carried on for 30 min at room temperature. Following staining, the
cells were washed twice again in PERM WASH buffer. After incu-
bation the cells were yet again washed twice in PBS and were per-
meabilized with FoxP3 permeabilization buffer (Becton Dickin-
son; USA) for 10 min at room temperature in the dark.  Following
this, they were stained with anti-FOXP3 antibodies for 30 min at
4°C in the dark. The stained cells were then washed and collected
using the FACSCanto flow cytometer (Becton Dickinson; USA).
Finally, they were analyzed with FACS Diva software (Becton
Dickinson; USA). Each time 3×104 events from the lymph gate
were saved for analysis. Logical gates were then used to analyze
particular populations of cells. At first, from the population of lym-
phocytes, the subpopulation of double CD25CD4 positive cells
was gated and the number of Foxp3 positive lymphocytes among
this population of cells (Gate P2) was estimated.
The CD14/B7H4 cells were stained using monoclonal antibod-
ies--CD14 FITC and B7H4 PE (E-Bioscience)--in the same way as
described for the Treg cells above, only the permeabilization step
was omitted. The analysis was also performed in the same way:
first the population of monocytes was determined (Gate 5), 5×104
events were collected from the gate set on CD14 positive cells
(Gate P8), and then the percentage of CD14/B7H4 positive cells in
the population of CD14+ cells was estimated.
Ethical issues. The patient's consent was obtained in each case.
Additionally, approval for the research program was granted from
the Ethical Committee of the Jagiellonian University in Krakow:
KBET/90/B/2005.
Statistical analysis. The distribution of variables in the study groups
of patients checked with the use of the Shapiro-Wilk test showed that
each of the patients was in fact different from normal. The statistical
significance between the groups was determined by the Kruskal-
Wallis test, one-way analysis of variance by ranks. The Mann-Whit-
ney U test was then used as applicable. All statistical analyses were
carried out with the Statistica 8.0 software program. A p value <0.05
was considered indicative of statistical significance. 
Results 
The two groups of nasal polyps were compared with
respect to the percentages of both FOXP3+ cells in the
subpopulations of CD25+CD4+ T regulatory cells and
B7H4+ cells in the larger subpopulation of macrophages.
The analysis of the CD25+CD4+FOXP3+ T
regulatory cells and suppressive B7H4+
macrophages in nasal polyps
We found statistically significant differences in the
percentages of FOXP3+ cells in the subpopulation of
CD25+CD4+ lymphocytes when the lymphocytic and
eosinophilic nasal polyps were compared.
We have noted a comparable percentage of CD4+
lymphocyte T in both groups of patients (respectively as
follows: Group ENP – 76.9% (±20.8); Group LNP
68.5% (±39.3). Additionally, we have also found a sta-
tistically significantly higher percentage of
CD4+CD25+ cells within the CD4+ T lymphocyte sub-
population in ENP groups than in LNP groups of patients
(respectively Group ENP – 9.9% (±4.3); Group LNP –
4.4% (±3.13); p=0.03). We also observed a statistically
significantly higher percentage of Foxp3 positive cells
within CD4+ lymphocytes in eosinophilic nasal polyps
than in lymphocytic nasal polyps (respectively Group
ENP – 2.3% (±2.00); Group LNP – 1.2% (±0.36)).
Likewise, we have found differences in the per-
centages of B7-H4 positive cells within the subpopula-
tion of CD14 positive macrophages in the different
types of nasal polyps.
No differences in the percentage of the CD14 posi-
tive macrophages were observed in the examined nasal
polyps (respectively Group ENP – 50.09% (±26.9);
Group LNP – 42.7% (±28.09).
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Fig. 1. The percentages of FOXP3+ cells in the subpopulation of
CD25+CD4+ lymphocytes in lymphocytic and eosinophilic nasal
polyps (NP). The cells isolated from both the lymphocytic NP (n-
6) and eosinophilic NP (n-8) were stained and analyzed for the
presence of regulatory T cells. The percentage of CD4+ CD25+
FOXP3+ cells was significantly higher in the eosinophilic NP than
the lymphocytic NP (p=0.03).
Table 1. The clinical characteristics of the subjects
Discussion
In our present study, we found that the percentages of
CD4+CD25+Foxp3+ Treg cells and of the B7-H4-
expressing macrophages were significantly higher in
the eosinophilic nasal polyps than in the lymphocytic
nasal polyps. 
To our knowledge this is the first investigation to
focus on the alterations in both Treg cells and B7-H4
macrophages in the stroma of nasal polyps with
respect to the predominant type of immune cell.
Both Th1- and Th2-type cytokines have been found
to be up-regulated in nasal polyps, regardless of the
atopic status of the patient [25,26]. CD4+CD25+ Treg
cells have been identified as a subpopulation of T cells
capable of down-regulating antigen-specific T-cell
responses [27]. It has recently been discovered that the
forkhead transcription factor Foxp3 is a more specific
marker for Tregs [8]. Moreover, Foxp3 may be natural-
ly induced in human T lymphocytes following their acti-
vation, and this induction is related to the acquisition of
the Treg phenotype in these cells [28]. The down-regu-
lation of Foxp3 has been observed in patients suffering
from nasal polyps, and an increase in the number of
these cells has been found following steroid therapy for
nasal polyps [14]. It has been proposed that low levels
of Foxp3 expression in nasal polyps may be related to
the persistence of the inflammation [14,29]. Moreover,
it has been demonstrated that allergic rhinitis is related
to a lower number of Foxp3 positive cells, which could
in turn be associated with the impaired regulatory activ-
ity of CD4+CD25+ T cells [30]. In fact, the effective-
ness of grass-pollen immunotherapy has been found to
be related to an increase in the number of CD25+,
Foxp3+, Foxp3+CD25+, and Foxp3+CD4+ cells in the
nasal mucosa of such patients in comparison with the
nasal mucosa of untreated patients [31]. Finally, it has
also been shown that the Treg cell CD4+CD25+Foxp3
has an intact regulatory function in atopic and allergic
patients [11]. As the percentage of Treg
CD4+CD25+Foxp3 cells was shown to be decreased in
nasal polyps, we were interested in any measurable dif-
ferences in the percentages of these cells with respect to
the different nasal polyp types. In the present study it
appeared that the percentage of the Treg
CD4+CD25+Foxp3 cells was significantly higher in
eosinophilic nasal polyps than in lymphocytic polyps.
The number of mononuclear cells, however, remained at
a comparable level in both groups of nasal polyps. It
seems that an aggressive inflammation in eosinophilic
nasal polyps elicits a higher infiltration of Treg cells
which, even though they are supposed to control and
restrict inflammation, seem to become ineffective. As
long as inflammation develops, an immunosuppressive
microenvironment is being created, and this will most
likely result in an ineffective immune response and con-
tinuing inflammation. The actual etiology of nasal
polyps, however, still remains unclear. Chronic rhinosi-
nusitis with nasal polyps is associated with a number of
diseases, including Samter's triad (aspirin sensitivity,
asthma, and nasal polyps), cystic fibrosis, and asthma.
The prevalence of chronic rhinosinusitis in the general
population is 4% [4]. Asthma has been reported in
patients with nasal polyps more frequently than in con-
trols (6%); 26% of patients with nasal polyps also have
asthma. Additionally, nasal polyps have been observed
in 36-96% of patients with aspirin sensitivity [4]. In our
present study, 35.7% of the patients had asthma; from
this group of patients 40% represented aspirin sensitive
individuals. We observed a statistically significantly
higher percentage of CD4+CD25+Foxp3+ Treg cells in
the nasal polyps derived from patients with bronchial
asthma (NPA) in comparison to the percentage found in
nasal polyps obtained from patients who did not suffer
from bronchial asthma (NPWA). No such difference,
however, was observed in the percentages of B7-H4-
expressing macrophages (the respective percentages of
B7-H4 positive macrophages within CD14 positive
cells were as follows: Group NPA- 31% (±20.99),
Group NPWA 24.3% (±16.9), p=0.6; respectively per-
centage of CD4+CD25+Foxp3+ Treg cells within
CD4+ lymphocytes Group NPA -54% (±7.78), Group
NPWA -39.7% (±5.06), p=0.01). Moreover, in our pres-
ent study, patients suffering from eosinophilic nasal
polyps also had bronchial asthma and aspirin sensitivity
more frequently than patients with lymphocytic nasal
polyps (Table 1). Moreover, the stage of the disease, as
determined by the CT score (Lund-Mackay), was more
advanced in patients with eosinophilic nasal polyps than
in patients with lymphocytic nasal polyps (Table 1).
Higher Treg and B7H4 positive cell percentages in
eosinophilic nasal polyps were therefore related to a
more clinically severe course of the disease. The sup-
pressive microenvironment in tumors is created not only
by the regulatory activity of Treg CD4+CD25+Foxp3+
cells, but also by macrophages [32]. With regard to
nasal polyps, suppressive macrophages expressing
RCAS1 have been identified only in eosinophilic nasal
polyps [5]. RCAS1 is responsible for the regulation of
the immune cell activity that inhibits the growth of
receptor expressing cells (T and B lymphocytes and NK
cells) both in vitro and in vivo and is also responsible for
inducing apoptosis [33]. In lymphocytic nasal polyps
the local immunosuppressive microenvironment may
not yet have been fully developed due to the duration of
the inflammation or because a different mechanism of
the disease was involved. In cases of autoimmune liver
diseases it has been demonstrated that the number of
RCAS1-expressing macrophages increased as the
inflammation and the severity of the disease progressed
(measured here by the Alat, Aspat levels) [34]. 
In our present study we identified a new subpopu-
lation of regulatory macrophages expressing the B7-
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H4 molecule that interact with Treg cells and create the
suppressive microenvironment found in nasal polyps.
Treg cells induce the secretion of high levels of IL-10
by APCs; IL-10 in turn stimulates the expression of
APC B7-H4 on APCs and renders APCs immunosup-
pressive through B7-H4 expression [22]. B7-H4-
expressing macrophages have also been found in
patients with ovarian cancer. These cells were able to
inhibit TAA (tumor associated antigen) -specific T-cell
proliferation, cytokine production, and cytotoxicity in
vitro. In vivo, B7-H4-expressing macrophages both
inhibited TAA-specific immunity and promoted tumor
growth [21,22]. Since the population of Treg cells is
limited and the mechanism of suppression is carried
out by a Treg to T cell contact, this may not provide
sufficient suppression in vivo. It has therefore been
postulated that Tregs are able to inhibit the function of
APCs, and the induction of B7-H4 macrophages may
be an important mechanism of this Treg-mediated reg-
ulation [22]. While Treg cells would seem to be the
first line of tolerance at the inflammation site, the
range of tolerance is actually determined by the Treg
cell number (in dose-dependent manner) [21,22].
Beyer and coworkers have suggested that Treg cells
are able to carry out their regulatory function in a cell-
contact and dose-dependent manner [10]. According to
other reports [21,22] B7-H4 macrophages may consti-
tute the second line of tolerance when Treg suppres-
sion is inefficient or exhausted as they can continue the
suppressive mode and recruit Treg cells. In a similar
way, the nasal polyp microenvironment may control
the growth and persistence of nasal polyps through the
development of local immune tolerance by recruiting
cells with regulatory activity, such as Treg cells and
B7-H4 macrophages. 
Immune suppression seems to be a complex phe-
nomenon involving Treg cells and B7-H4-expressing
macrophages. In conclusion, the alterations in both the
Treg cell and suppressive B7H4+ macrophage subpop-
Fig. 2. Treg CD4+CD25+Foxp3+
cells in eosinophilic nasal polyps. The
logical gating strategy for the estima-
tion of CD4+ CD25+ FOXP3+ Tregs
in eosinophilic NP:  A. gating on the
population of small lymphocytes
(Gate P1); B. gating on the population
of double positive CD4+CD25+ cells
(Gate P2); C. population of FoXp3
positive cells within CD4+CD25+
cells from Gate P2.
Fig. 3. Treg CD4+CD25+Foxp3+
cells in lymphocytic nasal polyps.
The logical gating strategy for the
estimation of CD4+ CD25+ FOXP3+
Tregs in lymphocytic NP: A. gating
on the population of small lympho-
cytes (Gate P1); B. gating on the pop-
ulation of double positive
CD4+CD25+ cells (Gate P2); C. pop-
ulation of FoXp3 positive cells with-
in CD4+CD25+cells from Gate P2.
Fig. 4. The percentages of B7-H4-positive cells within the sub-
population of CD14 positive macrophages in the lymphocytic and
eosinophilic nasal polyps. The cells isolated from the lymphocytic
NP (n-6) and eosinophilic NP (n-8) were stained and analyzed for
the presence of B7-H4 macrophages. The percentage of CD14+
B7-H4+ cells was significantly higher in the eosinophilic NP than
the lymphocytic NP (p=0.045).
ulations in the mucosa of nasal polyps may be related
to the restriction of an activation of an excessively
stimulated immune response. 
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ical gating strategy for the estimation
of CD14+ B7-H4+ macrophages in
eosinophilic NP:  A. gating on the
population of monocytes (Gate P5);
B. gating on the population of strong-
ly positive CD14+ cells (Gate P8); C.
population of B7-H4 positive cells
within CD14+cells from Gate P8.
Fig. 6. B7-H4-positive macrophages
in lymphocytic nasal polyps. The log-
ical gating strategy for the estimation
of CD14+ B7-H4+ macrophages in
lymphocytic NP:  A. gating on the
population of monocytes (Gate P5);
B. gating on the population of strong-
ly positive CD14+ cells (Gate P8); C.
population of B7-H4 positive cells
within CD14+cells from Gate P8.
[22] Kryczek I, Wei S, Zou L, Zhu G, Wei S, Mottram P, Brumlik
P, Cheng P, Curiel T,  Myers L, Lackner A,  Alvarez X, Ochoa
A, Chen L, Zou W. Cutting edge: induction of B7-H4 on
APCs through IL-10: novel suppressive mode for regulatory
T cells. J Immunol. 2006;177:40-44.
[23] Galazka K, Wicherek L, Pitynski K, Kijowski J, Zajac K,
Bednarek W, Dutsch-Wicherek M, Kalinka J, Basta A, Majka
M. Changes in the subpopulation of CD25+CD4+ and
FOXP3+ regulatory T cells in decidua with respect to the pro-
gression of labor at term and the lack of analogical changes in
the subpopulation of suppressive B7H4+ macrophages – a
preliminary report.  Am  J Reprod Immunol. 2009;61:136-
146.
[24] Wicherek L, Basta P, Pitynski K, Marianowski P, Kijowski J,
Wiatr J, Majka M. The characterization of the subpopulation
of suppressive B7H4(+) macrophages and the subpopulation
of CD25(+) CD4(+) and FOXP3(+) regulatory T-cells in
decidua during the secretory cycle phase, Arias Stella reac-
tion, and spontaneous abortion – a preliminary report. Am J
Reprod Immunol. 2009;61:303-312. 
[25] Sanchez-Segura A, Brieva JA, Rodriguez C. T lymphocytes
that infiltrate nasal polyps have a specialized phenotype and
produce a mixed Th1/Th2pattern of cytokines. J Allergy Clin
Immunol. 1998;102:953-960.
[26] Wagenmann M, Helmig P. Increased production of type-2 and
type-1 cytokines in nasal polyps. J Allergy Clin Immunol.
2000;(suppl 105):S210.
[27] Gershon RK, Kondo K. Cell interaction in the induction of
tolerance: the role of thymic lymphocytes. Immunology.
1970;18:723.
[28] Walker MR, Kasprowicz DJ, Gersuk VH, Benard A, Van Lan-
deghen M, Buckner JH, Ziegler SF. Induction of Foxp3 and
acquisition of T regulatory activity by stimulated human
CD4+CD25- T cells. J Clin Invest. 2003;112:1437-1443.
[29] Zhang N, Van Zele T, Perez-Novo C, Van Bruaene N,
Holtappels G, DeRuyck N, Van Cauvenberge P, and C.
Bachert C. Different types of T-effector cells orchestrate
mucosal inflammation in chronic sinus disease. J Allergy Clin
Immunol. 2008;122:961-968.
[30] Xu G, Mou Z, Jiang H, Cheng L, Shi J., Xu R, Oh Y, Li H. A
possible role of CD4+CD25+ T cells as well as transcription
factor Foxp3 in the dysregulation of allergic rhinitis. Laryn-
goscope. 2007;117:876-880.
[31] Radulovic S, Jacobson MR, Durham SR, Nouri-Aria KT.
Grass-pollen immunotherapy induces Foxp3-expressing
CD4+CD25+ cells in nasal mucosa. J Allergy Clin Immunol.
2008;121:1467-1472.
[32] Mantovani A, Romero P, Palucka AK, Marincola FM.
Tumour immunity: effector response to tumour and role of the
microenvironment. Lancet. 2008;371:771-783. 
[33] Matsushima T, Nakashima M, Oshima K, Abe Y, Nishimura
J, Nawata H, Watanabe T, Muta K. Receptor binding cancer
antigen expressed on SiSo cells, a novel regulator of apopto-
sis of erythroid progenitor cells. Blood. 2001;98:313-321.
[34] Enjoji M, Kotoh K, Nakashima M, Yoshimoto T, Miyagi Y,
Kohjima M, Nakamuta M. RCAS1-expressing macrophages
in inflammatory liver diseases. Liver Int. 2006;26;385-387.
Submitted: 25 May, 2010
Accepted after reviews: 4 August, 2010
617B7H4 + Macrophages and Treg cells in the Nasal Polyp microenvironment
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2010:48(4): 617 (611-617) 
Doi: 10.2478/v10042-010-0065-4
